Study Title: Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, John Kaczmar, at kaczmar@musc.edu, or please call +1 843-792-6691.Study Coordinator, Madison Avinger, at avingerm@musc.edu.Trial opened at the following institutions: Medical University of South Carolina